Eledon Pharmaceuticals (ELDN) Amortizatization of Intangibles (2015 - 2017)
Eledon Pharmaceuticals (ELDN) posted Amortizatization of Intangibles of -$1000.0 for Q1 2017, up 83.33% on a QoQ basis from -$6000.0 in Q4 2016, and up 97.3% year-over-year from -$506.85 in Q1 2016.
Eledon Pharmaceuticals (ELDN) Amortizatization of Intangibles (2015 - 2017) Analysis & Trends
Eledon Pharmaceuticals' Amortizatization of Intangibles history runs 3 years deep, the most recent figure standing at -$1000.0 for Q1 2017.
- Quarterly Amortizatization of Intangibles rose 97.3% year-over-year to -$1000.0 in Q1 2017, while the trailing twelve-month figure through Mar 2017 was -$79000.0 (changed N/A YoY) and the FY2016 annual result came in at -$115000.0, down 59.72% from the prior year.
- Amortizatization of Intangibles was -$1000.0 for Q1 2017 at Eledon Pharmaceuticals, up from -$6000.0 in the prior quarter.
- Across five years, Amortizatization of Intangibles topped out at -$1000.0 in Q1 2017 and bottomed at -$39000.0 in Q2 2016.
- A 3-year average of -$26714.3 and a median of -$33000.0 in 2015 frame the typical range for Amortizatization of Intangibles.
- Annual changes were most pronounced in 2016 — Amortizatization of Intangibles changed 0.0% — and 2017, when it soared 97.3%.
- Eledon Pharmaceuticals' Amortizatization of Intangibles stood at -$38000.0 in 2015, then surged by 84.21% to -$6000.0 in 2016, then jumped by 83.33% to -$1000.0 in 2017.
- Business Quant data shows ELDN's Amortizatization of Intangibles at -$1000.0 in Q1 2017, -$6000.0 in Q4 2016, and -$33000.0 in Q3 2016.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Amortizatization of Intangibles (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 66,621.14 Bn | 66,620.85 Bn | - | - |
| 2 | Nanobiotix | 1,915.18 Bn | 1,915.11 Bn | - | - |
| 3 | Akari Therapeutics | 1,014.18 Bn | 1,014.18 Bn | - | - |
| 4 | BeOne Medicines | 471.27 Bn | 466.48 Bn | 1.35 Bn | - |
| 5 | Vertex Pharmaceuticals | 121.81 Bn | 114.57 Bn | 2.59 Bn | - |
| 6 | Regeneron Pharmaceuticals | 69.58 Bn | 60.82 Bn | 3.31 Bn | - |
| 7 | Belite Bio | 62.72 Bn | 62.72 Bn | - | - |
| 8 | Argenx Se | 55.51 Bn | 50.33 Bn | 1.41 Bn | - |
| 9 | Revolution Medicines | 37.35 Bn | 37.35 Bn | - | 3.22 Mn |
| 10 | Eledon Pharmaceuticals | 399.11 Mn | 399.11 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2017 | -1,000.00 |
| Mar 31, 2017 | -1,000.00 |
| Dec 31, 2016 | -6,000.00 |
| Dec 31, 2016 | -6,000.00 |
| Sep 30, 2016 | -33,000.00 |
| Sep 30, 2016 | -33,000.00 |
| Jun 30, 2016 | -39,000.00 |
| Jun 30, 2016 | -39,000.00 |
| Mar 31, 2016 | -37,000.00 |
| Mar 31, 2016 | -37,000.00 |
| Dec 31, 2015 | -38,000.00 |
| Dec 31, 2015 | -38,000.00 |
| Sep 30, 2015 | -33,000.00 |
| Sep 30, 2015 | -33,000.00 |